The future of the global NGS-based RNA-sequencing market looks promising with opportunities in the research and academia, hospital and clinic, and pharmaceutical & biotechnology markets. The global NGS-based RNA-sequencing market is expected to reach an estimated $8.4 billion by 2030 with a CAGR of 17.6% from 2024 to 2030. The major drivers for this market are escalating demand for personalized medicine and rising awareness of the benefits of NGS-RNA-sequencing.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the NGS-based RNA-sequencing
market by product type (sample preparation products, RNA-sequencing platforms
and consumables, RNA-sequencing services, and data analysis, storage &
management), technology (sequencing by synthesis, ion semiconductor sequencing,
single-molecule real-time sequencing, and nanopore sequencing), application
(expression profiling analysis, small RNA-sequencing, de novo transcriptome
assembly, variant calling & transcriptome epigenetics, and others), end use
(research and academia, hospitals and clinics, pharmaceutical &
biotechnology, and others), and region (North America, Europe, Asia Pacific,
and the Rest of the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will
grow at a faster pace and why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the
emerging trends in this market and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market,
expression profiling analysis, small RNA-sequencing, de novo transcriptome
assembly, and variant calling & transcriptome epigenetics are the major
segments of NGS-based RNA-sequencing market by application. Lucintel forecasts
that expression profiling analysis will remain the largest region due to its
increasing demand in gene discovery, differential gene expression analysis, and
transcriptome profiling.
Within this market, research and academia is expected to witness highest growth over the forecast period.
North America will
remain the largest region due to high demand for personalized medicine,
existence of robust healthcare infrastructure, and presence of key players in
the region.
Illumina, Thermo Fischer
Scientific, Oxford Nanopore Technologies, Agilent Technologies, and Bgi are the
major suppliers in the NGS-based RNA-sequencing market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D
Printing Medical Device Market
8. Medical Lifting Sling
Market
10. Stretcher Market
No comments:
Post a Comment